TuHURA Biosciences Inc (HURA) Balance Sheet

NASDAQ: HURAAssets, liabilities, debt and equity over 10 years.

HURA balance sheet, FY2026

June 30, 2026 · U.S. dollars

$27.4M assets = $6.4M liabilities + $20.9M equity

Both columns are drawn to the same scale: what HURA owns equals what it owes plus shareholders’ equity. Hover a block for its value.

HURA financial health

Current ratio0.78

Tight · current assets cover current liabilities 0.78×

Debt / equity0.03

Low leverage · $0.03 of debt for each $1 of equity

Equity / assets76.5%

Equity-funded · of assets funded by shareholders

Cash / debt517.1%

Cash covers debt · cash & short-term investments vs total debt

Goodwill & intangibles80.5%

Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

HURA balance sheet trends, FY2017–FY2026

TuHURA Biosciences Inc balance sheet trends
Metric	Then	Latest	Change
Total assets	$7.9MFY2017	$27.4MFY2026	+14.8%/yr
Total liabilities	$1.3MFY2017	$6.4MFY2026	+19.1%/yr
Shareholders’ equity	$6.6MFY2017	$20.9MFY2026	+13.7%/yr
Cash & short-term investments	$6.6MFY2017	$3.6MFY2026	−6.4%/yr
Total debt	$644,070FY2022	$700,022FY2026	+2.1%/yr
Net cash (debt)	$4.9MFY2022	$2.9MFY2026	−$2.0M
Working capital	$6.6MFY2017	−$1.3MFY2026	−$7.9M
Book value per share	$0.78FY2025	$0.44FY2026	−44.1%/yr
Current ratio	6.03FY2017	0.78FY2026	−5.25
Debt / equity	0.01FY2023	0.03FY2026	+0.02
Shares outstanding	18.7MFY2025	47.9MFY2026	+156.8%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

HURA assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

HURA liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

HURA debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

HURA balance sheet

TuHURA Biosciences Inc annual balance sheet
	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Assets
Cash & short-term investments	$3.6M	$12.7M	$3.7M	$14.3M	$5.5M	$10.5M	$2.4M	$3.7M	$6.0M	$6.6M
Cash & equivalents	$3.6M	$12.7M	$3.7M	$14.3M	$5.5M	$10.5M	$2.4M	$3.7M	$6.0M	$6.6M
Receivables	$0	$222,702	$334,443	$101,424	$0	$0	$0	$26,187	$39,519	$76,595
Inventory	$0	$214,699	$0	$0	$0	$0	$0	$0	$0	$0
Other current assets	$1.0M	$6.5M	$159,326	$390,350	$135,128	$1.3M	$365,000	$280,248	$1.0M	$1.2M
Total current assets	$4.6M	$19.6M	$4.2M	$14.7M	$5.7M	$11.8M	$2.8M	$4.0M	$7.0M	$7.9M
Property, plant & equipment (net)	$685,169	$322,526	$202,990	$418,547	$617,139	$150,000	$2,000	$0	$0	$0
Goodwill & intangible assets	$22.0M	$0	$0	$0	$0	$0	$0	$12,062	$28,411	$40,290
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$33,769	$33,769	$0	$33,769	$103,902	$1.6M	$179,000	$0	$0	$0
Total assets	$27.4M	$20.0M	$4.4M	$15.2M	$6.4M	$13.5M	$2.9M	$4.0M	$7.1M	$7.9M
Liabilities
Accounts payable	$3.8M	$3.2M	$1.9M	$1.9M	$413,794	$2.2M	$2.0M	$1.7M	$1.5M	$1.3M
Short-term debt	$396,395	$159,844	$20,820	$117,481	$644,070	—	—	—	—	—
Total current liabilities	$5.9M	$5.3M	$3.6M	$2.9M	$7.2M	$2.8M	$2.7M	$2.1M	$1.6M	$1.3M
Long-term debt	$0	$0	$2.3M	$0	$0	$0	$0	$0	$0	$0
Lease obligations	$502,668	$202,542	$20,820	$138,224	$0	—	—	—	—	—
Other long-term liabilities	$501,546	$42,698	$0	$20,743	$0	$182,000	$0	$0	$1,117	$28,137
Total liabilities	$6.4M	$5.4M	$5.9M	$2.9M	$7.2M	$3.0M	$2.7M	$2.1M	$1.6M	$1.3M
Shareholders' equity
Common stock & paid-in capital	$59,336	$42,324	$6,801	$4,529	$4,529	$33,000	$11,000	$3,839	$22,967	$14,510
Retained earnings (deficit)	−$141.2M	−$111.1M	−$88.5M	−$59.2M	−$49.5M	−$111.2M	−$69.7M	−$60.6M	−$52.4M	−$41.1M
Accumulated other comprehensive income	—	—	—	—	—	$21,000	$21,000	$6.6M	$8.3M	$4.6M
Total shareholders' equity	$20.9M	$14.6M	−$1.6M	$12.3M	−$747,821	$10.6M	$263,000	$2.0M	$5.4M	$6.6M
Key figures
Total debt	$700,022	$202,542	$2.3M	$138,224	$644,070	—	—	—	—	—
Net cash (debt)	$2.9M	$12.5M	$1.3M	$14.1M	$4.9M	—	—	—	—	—
Working capital	−$1.3M	$14.3M	$562,422	$11.9M	−$1.5M	$9.0M	$82,000	$2.0M	$5.4M	$6.6M
Tangible book value	−$1.1M	$14.6M	−$1.6M	$12.3M	−$747,821	$10.6M	$263,000	$2.0M	$5.4M	$6.5M
Book value per share	$0.44	$0.78	—	—	—	—	—	—	—	—
Shares outstanding	47.9M	18.7M	—	—	—	—	—	—	—	—
Current ratio	0.78	3.68	1.16	5.13	0.79	4.24	1.03	1.94	4.30	6.03
Quick ratio	0.61	2.42	1.11	5.00	0.78	3.79	0.89	1.81	3.67	5.11
Debt / equity	0.03	0.01	—	0.01	—	—	—	—	—	—
Equity / assets	76.5%	73.1%	−35.7%	81.0%	−11.7%	78.1%	9.0%	48.7%	76.8%	83.2%

TuHURA Biosciences Inc quarterly balance sheet
	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23
Assets
Cash & short-term investments	$995,977	$6.3M	$3.6M	$2.7M	$8.5M	$6.2M	$12.7M	$3.0M	$4.9M	$4.5M	$658,000	$216,000
Cash & equivalents	$995,977	$6.3M	$3.6M	$2.7M	$8.5M	$6.2M	$12.7M	$3.0M	$4.9M	$4.5M	$658,000	$216,000
Short-term investments	—	—	—	—	—	—	$6.0M	—	—	—	—	—
Receivables	$0	$0	$0	$214,699	$3.0M	$95,553	$222,702	$258,000	$0	$334,443	$103,000	$0
Inventory	$0	$0	$0	$0	$0	$0	$214,699	$0	$0	$0	$0	$0
Other current assets	$659,889	$684,156	$1.0M	$591,730	$1.0M	$8.0M	$6.5M	$205,000	$619,000	$500,971	$425,000	$567,000
Total current assets	$1.7M	$7.0M	$4.6M	$3.5M	$12.5M	$14.3M	$19.6M	$3.5M	$5.5M	$5.3M	$1.2M	$783,000
Property, plant & equipment (net)	$745,668	$675,645	$685,169	$378,039	$144,171	$313,297	$322,526	$657,000	$674,000	$455,044	$699,000	$694,000
Goodwill & intangible assets	$22.0M	$22.0M	$22.0M	$21.8M	$21.8M	$0	$0	$0	$0	$0	$0	$0
Long-term investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Other non-current assets	$7.3M	$33,769	$33,769	$0	$122,511	$0	$33,769	$0	$0	$33,769	$0	$0
Total assets	$31.7M	$29.7M	$27.4M	$25.7M	$34.6M	$14.6M	$20.0M	$4.1M	$6.2M	$5.8M	$1.9M	$1.5M
Liabilities
Accounts payable	$3.1M	$4.0M	$3.8M	$4.1M	$3.6M	$3.1M	$3.2M	$1.3M	$2.2M	$1.6M	$1.7M	$3.0M
Short-term debt	$214,175	$206,851	$396,395	$577,732	$558,969	$164,594	$159,844	—	—	$146,282	—	—
Total current liabilities	$9.3M	$6.1M	$5.9M	$8.8M	$15.2M	$4.8M	$5.3M	$5.4M	$2.3M	$4.8M	$1.9M	$3.3M
Long-term debt	$3.6M	$0	$0	$0	$0	$0	$0	$0	$0	$6.8M	$0	$0
Lease obligations	$407,023	$456,926	$502,668	$84,346	$124,969	$164,594	—	—	—	$310,876	—	—
Other long-term liabilities	$390,767	$447,993	$501,546	$84,985	$0	$0	$42,698	$24.5M	$186,000	$164,594	$179,000	$167,000
Total liabilities	$13.2M	$6.5M	$6.4M	$8.9M	$15.2M	$4.8M	$5.4M	$2.4M	$2.4M	$11.9M	$2.0M	$3.5M
Shareholders' equity
Common stock & paid-in capital	$63,682	$63,577	$59,336	$51,255	$49,913	$43,680	$42,324	$7,637	$55,000	$6,807	$10,000	$2,000
Retained earnings (deficit)	−$157.9M	−$148.7M	−$141.2M	−$134.4M	−$127.3M	−$117.8M	−$111.1M	−$162.1M	−$159.9M	−$93.3M	−$155.5M	−$154.5M
Accumulated other comprehensive income	—	—	—	—	—	−$3.1M	—	$21,000	$21,000	—	$21,000	$21,000
Total shareholders' equity	$18.5M	$23.2M	$20.9M	$16.8M	$19.4M	$9.9M	$14.6M	$1.7M	$3.8M	−$6.1M	−$164,000	−$2.0M
Key figures
Total debt	$407,023	$456,926	$700,022	$577,732	$558,969	$164,594	$202,542	—	—	$7.2M	—	—
Net cash (debt)	$588,954	$5.8M	$2.9M	$2.1M	$8.0M	$6.1M	$12.5M	—	—	−$2.7M	—	—
Working capital	−$7.6M	$915,379	−$1.3M	−$5.3M	−$2.6M	$9.5M	$14.3M	−$1.9M	$3.3M	$454,857	−$684,000	−$2.6M
Tangible book value	−$3.5M	$1.2M	−$1.1M	−$5.0M	−$2.4M	$9.9M	$14.6M	$1.7M	$3.8M	−$6.1M	−$164,000	−$2.0M
Book value per share	$0.29	$0.39	$0.44	$0.33	$0.44	$0.23	$0.34	—	—	—	—	—
Shares outstanding	64.0M	60.0M	47.9M	50.7M	44.6M	43.4M	42.3M	—	—	—	—	—
Current ratio	0.18	1.15	0.78	0.40	0.83	3.00	3.68	0.64	2.45	1.09	0.63	0.23
Quick ratio	0.11	1.04	0.61	0.33	0.76	1.32	2.42	0.60	2.17	0.99	0.41	0.06
Debt / equity	0.02	0.02	0.03	0.03	0.03	0.02	0.01	—	—	—	—	—
Equity / assets	58.3%	78.1%	76.5%	65.3%	56.2%	67.3%	73.1%	40.9%	60.6%	−104.8%	−8.7%	−137.2%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 31, 2026); data from EODHD.

HURA financial position

At the end of fiscal 2026 (June 30, 2026), TuHURA Biosciences had total assets of $27.4 million (up 37.0% from a year earlier), total liabilities of $6.4 million and shareholders' equity of $20.9 million. It held $3.6 million in cash and short-term investments against $0.7 million of debt, a net cash position of $2.9 million. Its current ratio was 0.78.

Related: HURA income statement, HURA cash flow statement, HURA key metrics. See the HURA stock overview for the latest quote and news.

HURA balance sheet FAQ

What are TuHURA Biosciences's total assets?

TuHURA Biosciences reported total assets of $27.4 million at the end of fiscal 2026 (June 30, 2026), compared with $20.0 million a year earlier.

How much debt does TuHURA Biosciences have?

TuHURA Biosciences had $0.7 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.03.

How much cash does TuHURA Biosciences have?

TuHURA Biosciences held $3.6 million in cash and short-term investments at the end of fiscal 2026; with $0.7 million of debt that is net cash of $2.9 million.

What is TuHURA Biosciences's book value?

TuHURA Biosciences's shareholders' equity (book value) was $20.9 million at the end of fiscal 2026, or $0.44 per share.

What is TuHURA Biosciences's current ratio?

TuHURA Biosciences had current assets of $4.6 million and current liabilities of $5.9 million, a current ratio of 0.78 (current liabilities exceed current assets).

How much goodwill does TuHURA Biosciences have?

TuHURA Biosciences carried $22.0 million of goodwill and intangible assets, 80.5% of total assets, at the end of fiscal 2026.